Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-047529
Filing Date
2021-07-20
Accepted
2021-07-20 21:34:58
Documents
1
Period of Report
2021-07-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14468
  Complete submission text file 0001209191-21-047529.txt   16171
Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
Celularity Inc (Issuer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
GX Sponsor LLC (Reporting) CIK: 0001752834 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38914 | Film No.: 211102567